Evidence map›Paper›PMID 40572723›Full record

ArticleMedicina (Kaunas, Lithuania)2025

The Effect of MicroRNA 21 and MicroRNA 200b Expression on Carcinogenesis in Endometriosis-Associated Ovarian Cancers and Relationship with Clinicopathological Parameters.

Esra Canan Kelten Talu, Emine Çağnur Ulukuş, Yasemin Çakır, Merih Güray Durak, Zeynep Bayramoğlu, Hikmet Tunç Timur, Sefa Kurt, Sefai Merve Özdemir, Safiye Aktaş

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Esra Canan Kelten TaluDepartment of Pathology, Tepecik Training and Research Hospital, Izmir Faculty of Medicine, University of Health Sciences, Izmir 35540, Türkiye.
Emine Çağnur UlukuşDepartment of Pathology, Memorial Ataşehir Hospital, Istanbul 34750, Türkiye.
Yasemin ÇakırDepartment of Pathology, Faculty of Medicine, DokuzEylul University, Izmir 35340, Türkiye.
Merih Güray DurakDepartment of Pathology, Faculty of Medicine, DokuzEylul University, Izmir 35340, Türkiye.ORCID 0000-0003-3516-952X
Zeynep BayramoğluDepartment of Pathology, Faculty of Medicine, DokuzEylul University, Izmir 35340, Türkiye.
Hikmet Tunç TimurDepartment of Obstetrics and Gynaecology, Faculty of Medicine, DokuzEylul University, Izmir 35340, Türkiye.
Sefa KurtDepartment of Obstetrics and Gynaecology, Faculty of Medicine, DokuzEylul University, Izmir 35340, Türkiye.
Sefai Merve ÖzdemirDepartment of Basic Oncology, Institute of Oncology, DokuzEylul University, Izmir 35330, Türkiye.
Safiye AktaşDepartment of Molecular Pathology, Faculty of Medicine, Institute of Health Sciences, DokuzEylul University, Izmir 35410, Türkiye.ORCID 0000-0002-7658-5565

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1)

Indexed as

CarcinogenesisEndometriosisMicroRNAsOvarian NeoplasmsAdultEndometriumFemaleHumansMiddle AgedMicroRNAsMIRN200 microRNA, humanMIRN21 microRNA, humanbiomarkerclinicopathological findingsendometriosisendometriosis-associated ovarian cancermiRNA 200bmiRNA 21

Identifiers

PMID40572723
PMCPMC12195162

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.